NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/07/2023
Voltar para busca
Dado oficial do USPTO
MP
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000088627756Classe
1, 5, 7, 9, 10, 35, 42
Pedido
88627756
Registro
7101162
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
13/01/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 7, 9, 10, 35, 42
Data de depósito
23/09/2019
Data de registro
04/07/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/07/2023
Última transação
13/01/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
17/12/2005
Primeiro uso no comércio
17/12/2005
Código do desenho
3
Tipo de titular
16
Localização do titular
Irvine, CA, US
Examinador
VENGURLEKAR, SAGAR
Unidade examinadora
M80
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized letters "MP" with square boxes sitting to the right. The designs of a symbolic antibody, fullerene, and double helix appear within the square boxes.
Titulares e representantes
Titulares
MP BIOMEDICALS, LLC
MP BIOMEDICALS, LLC
Representantes
Jonathan A. Menkes KNOBBE, MARTENS, OLSON & BEAR, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 7Classe 9Classe 10Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biochemicalsprecursors for in vitro genetic engineering use; Polypeptides for in vitro research use; Monoclonal antibodies for in vitro scientific or research use; Cells for scientificlaboratory or medical research; diagnostic preparations or reagents for scientific research; Diagnostic reagents for in vitro testing in clinical laboratories; Reagents for testing the sterility of medical equipment; Reagents for testing the sterility of pharmaceuticals and injectable solutions; Agentsreagentsassaysenzymesnucleotidesbufferschemical preparationsbiological preparations for scientific and research use; diagnostic reagents and preparationsother than for medical or veterinary use; Kits containing reagents and a protocol for use thereof for non-medical purposes; Agentsreagentsassaysenzymesnucleotidesbufferschemical preparationsbiological preparations for scientific and research usediagnosticsdiagnostic researchclinical researchdrug developmentpharmaceuticalslaboratory researchscientific researchmedical researchlife sciencesbiologymicrobiologybiotechnologyagricultureforensicsfood safetynot for medical or veterinary purposes; Kits comprising nucleotidesreagentsenzyme substratesbufferschemical preparationsbiological preparations for scientific and research use including in the fields of diagnosticsdiagnostic researchclinical researchdrug developmentpharmaceuticalslaboratory researchscientific researchmedical researchlife sciencesbiologymicrobiologybiotechnologyagricultureforensicsfood safetynot for medical or veterinary purposes
Classe 5
Cells for medical or clinical use; diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for clinical or medical laboratory use; diagnostic preparations or reagents for medical use; clinical medical reagents; medical diagnostic reagents Agentsreagentsassaysenzymesnucleotidesbufferschemical preparationsbiological preparations for medical use; diagnostic reagents and preparations for medical use; kits containing reagents and a protocol for use thereof for medical purposes; kits comprised of nucleotidesreagentsenzyme substratesbufferschemical preparationsbiological preparations for medical testing and medical diagnostic purposes; agentsreagentsassaysenzymesnucleotidesbufferschemical preparationsbiological preparations for medical use in the fields of medical diagnosticsclinical diagnosticsmedical forensicslaboratory medicine
Classe 7
Centrifugal pumps and centrifugal separators; centrifuges
Classe 9
Laboratory apparatuscentrifuges; Laboratory consumablespipette tips; Laboratory apparatus and instruments for testing gasliquidssolids; Diagnostic apparatus for the detection of pathogens for laboratory or research use; scientific and laboratory apparatus for use in shaking vessels with a reciprocating motion; Laboratory apparatussample disruption instruments designed to homogenizegrindlyse biological samples
Classe 10
Containers for medical waste; Tubes for samplespipette tipspetri dishescollection containers for medical laboratory samplesfilters for medical laboratory usepipettes for medical useall the afore-mentioned goods for medical purposes only; Laboratory articles made of plastic for medical purposes onlycontainerstubes
Classe 35
Providing online retail store services featuring a variety of laboratory equipmentkitspreparationsinstruments
Classe 42
Product research and development; research and development for new products for others
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
04/07/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/06/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/06/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
27/04/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
27/04/2023
IUAF
USE AMENDMENT FILED
10/04/2023
EISU
TEAS STATEMENT OF USE RECEIVED
10/04/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
18/10/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/08/2022
PUBO
PUBLISHED FOR OPPOSITION
23/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/07/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
21/07/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
21/07/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
21/07/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
21/07/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
25/01/2022
GNFR
FINAL REFUSAL E-MAILED
25/01/2022
CNFR
FINAL REFUSAL WRITTEN
25/01/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
03/01/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
23/06/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
22/12/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
22/06/2020
GNSL
LETTER OF SUSPENSION E-MAILED
22/06/2020
CNSL
SUSPENSION LETTER WRITTEN
22/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/06/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/12/2019
GNRT
NON-FINAL ACTION E-MAILED
22/12/2019
CNRT
NON-FINAL ACTION WRITTEN
22/12/2019
DOCK
ASSIGNED TO EXAMINER
22/12/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
28/09/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/09/2019
NWAP
NEW APPLICATION ENTERED
26/09/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MP ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.